CSBR
Champions Oncology·NASDAQ
--
--(--)
--
--(--)
6.55 / 10
Outperform
CSBR's fundamentals show satisfactory quality with a score of 6.5/10. Key strengths include a healthy Days sales outstanding at 65.62 and an Interest coverage ratio of 42.48, both in favorable quartiles. Growth metrics like Total operating revenue and Operating revenue YoY are positive at 13.54%, indicating operational momentum. However, PB-ROE is elevated at 1.90, placing it in a less favorable quartile and balancing the profile. Overall, the fundamental picture is mixed but leans positive, supporting an Outperform rating.
Analysis Checks(9/10)
Revenue-MV
Value-0.42
Score3/3
Weight18.07%
1M Return10.54%
Value-0.42
Score3/3
Weight18.07%
1M Return10.54%
Days sales outstanding
Value65.62
Score2/3
Weight1.57%
1M Return1.10%
Value65.62
Score2/3
Weight1.57%
1M Return1.10%
Net income-Revenue
Value0.15
Score3/3
Weight17.14%
1M Return9.29%
Value0.15
Score3/3
Weight17.14%
1M Return9.29%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Asset-MV
Value-1.90
Score3/3
Weight26.71%
1M Return13.15%
Value-1.90
Score3/3
Weight26.71%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value13.54
Score2/3
Weight1.54%
1M Return1.11%
Value13.54
Score2/3
Weight1.54%
1M Return1.11%
Profit-MV
Value-2.42
Score3/3
Weight17.36%
1M Return9.28%
Value-2.42
Score3/3
Weight17.36%
1M Return9.28%
PB-ROE
Value1.90
Score0/3
Weight4.30%
1M Return2.72%
Value1.90
Score0/3
Weight4.30%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value13.54
Score2/3
Weight0.59%
1M Return0.43%
Value13.54
Score2/3
Weight0.59%
1M Return0.43%
Cash-MV
Value0.41
Score2/3
Weight14.16%
1M Return8.41%
Value0.41
Score2/3
Weight14.16%
1M Return8.41%
Revenue-MV
Value-0.42
Score3/3
Weight18.07%
1M Return10.54%
Value-0.42
Score3/3
Weight18.07%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value13.54
Score2/3
Weight1.54%
1M Return1.11%
Value13.54
Score2/3
Weight1.54%
1M Return1.11%
Days sales outstanding
Value65.62
Score2/3
Weight1.57%
1M Return1.10%
Value65.62
Score2/3
Weight1.57%
1M Return1.10%
Profit-MV
Value-2.42
Score3/3
Weight17.36%
1M Return9.28%
Value-2.42
Score3/3
Weight17.36%
1M Return9.28%
Net income-Revenue
Value0.15
Score3/3
Weight17.14%
1M Return9.29%
Value0.15
Score3/3
Weight17.14%
1M Return9.29%
PB-ROE
Value1.90
Score0/3
Weight4.30%
1M Return2.72%
Value1.90
Score0/3
Weight4.30%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.44%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value13.54
Score2/3
Weight0.59%
1M Return0.43%
Value13.54
Score2/3
Weight0.59%
1M Return0.43%
Asset-MV
Value-1.90
Score3/3
Weight26.71%
1M Return13.15%
Value-1.90
Score3/3
Weight26.71%
1M Return13.15%
Cash-MV
Value0.41
Score2/3
Weight14.16%
1M Return8.41%
Value0.41
Score2/3
Weight14.16%
1M Return8.41%
Is CSBR undervalued or overvalued?
- CSBR scores 6.55/10 on fundamentals and holds a Discounted valuation at present. Backed by its -4.22% ROE, 4.16% net margin, 36.51 P/E ratio, 21.50 P/B ratio, and 460.00% earnings growth, these metrics solidify its Outperform investment rating.
